Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against MacroGenics, Inc. - MGNX


NEW YORK, Aug. 1, 2024 /PRNewswire/ -- LLP announces that a class action lawsuit has been filed against MacroGenics, Inc. ("MacroGenics" or the "Company") (NASDAQ: MGNX).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

The class action concerns whether MacroGenics and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

You have until September 24, 2024, to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired MacroGenics securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.     

[Click here for information about joining the class action]

On May 9, 2024, MacroGenics issued a press release disclosing the deaths of five patients in the Company's Phase 2 TAMARACK study of vobramitamab duocarmazine (vobra duo) in patients with metastatic astration. 

On this news, MacroGenics' stock price fell $11.36 per share, or 77.4%, to close at $3.31 per share on May 10, 2024.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.   

Attorney advertising.  Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP


These press releases may also interest you

at 17:30
Sparton Resources , ("the Company") is pleased to report that Ivanhoe Electric Inc. announced today that definitive agreements have been signed between VRB Energy Inc. ("VRB Energy"), and a subsidiary of privately held Shanxi Red Sun Co., Ltd. ("Red...

at 17:30
The Container Store Group, Inc. today announced that its second quarter fiscal 2024 financial results will be released after market close on Tuesday, October 29, 2024. The Company will host a conference call at 4:30 p.m. Eastern Time to discuss the...

at 17:25
Cryo-Cell International, Inc. (the "Company"), the world's first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2024. Financial Results Revenue Consolidated...

at 17:25
Equity Bancshares, Inc. , ("Equity", "the Company," "we," "us," "our"), the Wichita-based holding company of Equity Bank, reported net income of $19.8 million or $1.28 earnings per diluted share for the quarter ended September 30, 2024. "Our Company...

at 17:24
Trading resumes in: Company: Axcap Ventures Inc. CSE Symbol: AXCP All Issues: Yes Resumption (ET): 8:00 am 10/16/2024 CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading...

at 17:15
The following issues have been halted by CIRO: Company: Stack Capital Group Inc. TSX Symbol: STCK All Issues: Yes Reason: Pending News Halt Time (ET): 3:53 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security...



News published on and distributed by: